In Part 1 of our interview with Robert Klitzman, MD, ethics professor at Columbia University, we discuss the 23andMe genetic test kit company and why the FDA made them stop marketing the tests.
The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data making the national news came from the PCSK9-antibody drugs (evolocumab and alirocumab) that dramatically Read more »
Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper he co-wrote with his sister, Monica Gandhi, MD, discussing the current state of therapy for HIV-infected patients. He then addresses the ways to prevent HIV infection either after or before exposure.
In June of 2012, The Healthcare Channel published an influential Op-Ed in the WSJ exposing an $11 Billion program of the ACA Law (ObamaCare) as pure pork. The Director of the Program, Richard Gilfillan, MD, made a rare rebuttal in public. Read more »
The Wall Street Journal published an article explaining how the pharmaceutical industry data mines credit card records, Internet traffic patterns, and other personal data on individuals, then forms educated guesses Read more »
The large health insurance company now called Anthem, formerly known as WellPoint (which owns Blue Cross plans, adding to the confusion of nomenclature) is making national news for announcing thatRead more »